Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the safety, tolerability and efficacy of MT101-5 in subjects with early Parkinson's disease; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• MT101-5

Snippet

Sponsor: Mthera Pharma Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: NOT_YET_RECRUITING